MedTrace Logo

View of Cerebral Perfusion in Liver Transplantation

NCT07442214 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2026-03-02

No results posted yet for this study

Summary

Investigator's aim in this study is to compare the more accessible and low-cost Carotid Doppler USG measurements, which are relatively more difficult to access, costly, and have technical disadvantages, and to demonstrate their superiority over each other in the evaluation of cerebral perfusion in liver transplantation surgeries, without any invasive intervention to the patient.

Conditions

  • End-stage Liver Disease (ESLD)
  • Liver Transplantation
  • Cerebral Perfusion
  • Intraoperative Monitoring

Interventions

DEVICE

Carotid Doppler Ultrasonography and Near-Infrared Spectroscopy (NIRS)

Non-invasive intraoperative monitoring of cerebral perfusion using NIRS and carotid Doppler.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-04-01
Completion
2026-04-15
FDA Device
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07442214 on ClinicalTrials.gov